Health & Medicine May 13, 2026 · 4 min
Part 52: Pharmacological Economics — The 'Half-Life/Price' Value Rankings
Identifying the most cost-effective long-acting substances in the Jan Aushadhi portfolio. Rankings based on Half-Life per Rupee of daily dosage. Expanded to include 350+ formulations.
#jan-aushadhi#pharmacology#half-life
